Eltrombopag | SB-497115 | Thrombopoietin Receptor | AmBeed-信号通路专用抑制剂

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	1周咨询	- +

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT00529568	Hepatitis C, Chronic	Phase 3	Completed	-	-
NCT00370331	Purpura, Thrombocytopaenic, Id... 展开 >>iopathic 收起 <<	Phase 3	Completed	-	-
NCT01864512	-		Withdrawn(No eligible patient ... 展开 >>was enrolled.) 收起 <<	April 2014	China, Shandong ... 展开 >> Qilu Hospital, Shandong University Jinan, Shandong, China, 250012 收起 <<
NCT00370331	-		Completed	-	-
NCT00833378	Hepatitis C	Phase 1	Completed	-	United States, New York ... 展开 >> GSK Investigational Site Buffalo, New York, United States, 14202 收起 <<
NCT03025698	Aplastic Anemia	Phase 2	Recruiting	April 1, 2024	-
NCT00688272	Purpura, Thrombocytopaenic, Id... 展开 >>iopathic 收起 <<	Phase 1	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site Dundee, United Kingdom, DD1 9SY 收起 <<
NCT00529568	-		Completed	-	-
NCT01623167	Severe Aplastic Anemia	Phase 1 Phase 2	Recruiting	January 30, 2024	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov 收起 <<
NCT01433978	Idiopathic Thrombocytopenic Pu... 展开 >>rpura 收起 <<	Phase 3	Terminated(Study was terminate... 展开 >>d early due to significant enrollment challenges.) 收起 <<	-	United States, South Dakota ... 展开 >> Prairie Lakes Health Care System Watertown, South Dakota, United States 收起 <<
NCT01890746	Leukaemia, Acute	Phase 2	Completed	-	-
NCT01433978	-		Terminated(Study was terminate... 展开 >>d early due to significant enrollment challenges.) 收起 <<	-	-
NCT01113502	Male and Female Subjects, Grea... 展开 >>ter Than 60 Years of Age With Non-M3 AML 收起 <<	Phase 1 Phase 2	Completed	-	United States, Pennsylvania ... 展开 >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 <<
NCT00909363	Wiskott-Aldrich Syndrome ... 展开 >> Thrombocytopenia Bleeding 收起 <<	Phase 2	Active, not recruiting	June 2020	United States, New York ... 展开 >> Weill Cornell Medical College New York, New York, United States, 10065 收起 <<
NCT00359463	Purpura, Thrombocytopaenic, Id... 展开 >>iopathic 收起 <<	Phase 1	Completed	-	United States, Florida ... 展开 >> GSK Investigational Site Gainesville, Florida, United States, 32608 GSK Investigational Site Orlando, Florida, United States, 32809 Australia, New South Wales GSK Investigational Site Randwick, Sydney, New South Wales, Australia, 2031 Australia, South Australia GSK Investigational Site Adelaide, South Australia, Australia, 5000 New Zealand GSK Investigational Site Christchurch, New Zealand, 8011 收起 <<
NCT01440374	Thrombocytopaenia	Phase 2	Completed	-	-
NCT01890746	-		Completed	-	-
NCT00861601	-		Completed	-	-
NCT01416311	-		Active, not recruiting	October 20, 2020	-
NCT01440374	-		Completed	-	-
NCT00903422	Myelodysplastic Syndrome	Phase 1	Completed	-	-
NCT00861601	Liver Diseases	Phase 2	Completed	-	Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 810-8563 GSK Investigational Site Fukuoka, Japan, 814-0180 GSK Investigational Site Fukuoka, Japan, 815-8555 GSK Investigational Site Fukuoka, Japan, 830-0011 GSK Investigational Site Fukuoka, Japan, 839-0863 GSK Investigational Site Kagoshima, Japan, 890-8520 GSK Investigational Site Kumamoto, Japan, 860-8556 GSK Investigational Site Kumamoto, Japan, 862-8655 GSK Investigational Site Nagasaki, Japan, 856-8562 GSK Investigational Site Oita, Japan, 879-5593 收起 <<
NCT00442871	Purpura, Thrombocytopaenic, Id... 展开 >>iopathic 收起 <<	Phase 1	Completed	-	United States, Florida ... 展开 >> GSK Investigational Site Gainesville, Florida, United States, 32608 United States, Minnesota GSK Investigational Site Saint Paul, Minnesota, United States, 55114-1067 收起 <<
NCT02928419	Myelodysplastic Syndromes	Phase 2	Terminated("the study has been... 展开 >> closed due to a low rate of patient enrollment (2 patients since the start of the trial)") 收起 <<	-	-
NCT01064336	-		Completed	-	-
NCT00908037	Purpura, Thrombocytopaenic, Id... 展开 >>iopathic 收起 <<	Phase 2	Completed	-	-
NCT01098487	Purpura, Thrombocytopaenic, Id... 展开 >>iopathic 收起 <<	Phase 4	Completed	-	-
NCT00908037	-		Completed	-	-
NCT01098487	-		Completed	-	-
NCT01147809	-		Completed	-	-
NCT00540423	-		Completed	-	-
NCT02877212	Immune Thrombocytopenic Purpur... 展开 >>a (ITP) 收起 <<	Phase 3	Unknown	September 2017	Pakistan ... 展开 >> Armed Forces Bone Marrow Transplant Centre Recruiting Rawalpindi, Punjab, Pakistan, 46000 Contact: Parvez Ahmed, FCPS, MCPS +92-51-9270076 ext 201 pahmed101@yahoo.com Contact: Andleeb Hanif, M.Phil +92-51-9270076 ext 232 andleebhanif123@gmail.com Principal Investigator: Parvez Ahmed, FCPS, MCPS Sub-Investigator: Andleeb Hanif, M.Phil Sub-Investigator: Tariq M Satti, FCPS Sub-Investigator: Qamar Un Nisa Ch, FCPS Sub-Investigator: Kamran Mehmood, FCPS 收起 <<
NCT02446145	Acute Myeloid Leukemia	Phase 2	Recruiting	May 2019	Germany ... 展开 >> Uniklinik RWTH Aachen Recruiting Aachen, Germany Contact: Martina Crysandt, MD Charite Campus Benjamin Franklin Not yet recruiting Berlin, Germany Contact: Claudia Baldus, Prof. Klinikum Chemnitz GmbH Recruiting Chemnitz, Germany Contact: Mathias Hänel, MD Universitätsklinikum Dresden Recruiting Dresden, Germany Contact: Uwe Platzbecker, Prof. Marienhospital Düsseldorf GmbH Not yet recruiting Düsseldorf, Germany Contact: Aristoteles Giagounidis, MD Universitätsklinikum Essen Recruiting Essen, Germany Contact: Richard Noppeney, MD Universitätsklinikum Halle (Saale) Recruiting Halle, Germany Contact: Petra Tschanter, MD St. Marien-Hospital Hamm Not yet recruiting Hamm, Germany Contact: Heinz A Dürk, MD Klinikum rechts der Isar der TU München Not yet recruiting München, Germany Contact: Katharina Götze, MD Klinikum Nürnberg-Nord Recruiting Nürnberg, Germany Contact: Kerstin Schäfer-Eckart, MD Medizinisches Versorgungszentrum für Blut- und Krebserkrankungen Recruiting Potsdam, Germany Contact: Hartmut Linde, MD Wissenschaftskontor Nord GmbH & Co KG Not yet recruiting Rostock, Germany Contact: Andreas Lück, MD Diakonie-Klinikum Schwäbisch Hall gGmbH Recruiting Schwäbisch Hall, Germany Contact: Thomas Geer, MD Rems-Murr-Klinikum Winnenden Recruiting Winnenden, Germany Contact: Stefani Parmentier, MD Universitätsklinikum Würzburg Not yet recruiting Würzburg, Germany Contact: Volker Kunzmann, Prof. 收起 <<
NCT00358540	Thrombocytopaenia	Phase 1	Completed	-	United States, California ... 展开 >> GSK Investigational Site Santa Monica, California, United States, 90403 United States, Florida GSK Investigational Site Miami, Florida, United States, 33136 GSK Investigational Site Tampa, Florida, United States, 33612 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19106 United States, South Carolina GSK Investigational Site Greenville, South Carolina, United States, 29605 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75246 GSK Investigational Site Houston, Texas, United States, 77030-4009 收起 <<
NCT01328587	Moderate Aplastic Anemia ... 展开 >> Unilineage Bone Marrow Failure Disorders 收起 <<	Phase 2	Active, not recruiting	March 30, 2025	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT01147809	Thrombocytopaenia	Phase 2	Completed	-	-
NCT00424177	Purpura, Thrombocytopaenic, Id... 展开 >>iopathic 收起 <<	Phase 2	Completed	-	Germany ... 展开 >> GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Berlin, Germany, 13353 Russian Federation GSK Investigational Site Moscow, Russian Federation, 125167 收起 <<
NCT00487968	Healthy Subjects ... 展开 >> Purpura, Thrombocytopenic, Idiopathic 收起 <<	Phase 1	Completed	-	United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 <<
NCT00540423	Chronic Idiopathic Thrombocyto... 展开 >>penic Purpura Purpura, Thrombocytopenic, Idiopathic 收起 <<	Phase 3	Completed	-	Japan ... 展开 >> GSK Investigational Site Gifu, Japan, 503-8502 GSK Investigational Site Hiroshima, Japan, 734-8551 GSK Investigational Site Ibaraki, Japan, 305-8576 GSK Investigational Site Osaka, Japan, 565-0871 GSK Investigational Site Osaka, Japan, 596-8501 GSK Investigational Site Tochigi, Japan, 329-0498 GSK Investigational Site Tokyo, Japan, 160-8582 收起 <<
NCT02158936	Thrombocytopaenia	Phase 3	Terminated	-	-
NCT02912208	Myelodysplastic Syndromes ... 展开 >> Thrombocytopenia 收起 <<	Phase 2	Recruiting	June 2019	-
NCT02834286	Immune Thrombocytopenia	Phase 2	Unknown	September 2017	Mexico ... 展开 >> Servicio de Hematología, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León Recruiting Monterrey, Nuevo León, Mexico, 64460 Contact: Perla R Colunga, MD +558110761973 colunga.perla@gmail.com Principal Investigator: David Gómez-Almaguer, MD Sub-Investigator: Perla R. Colunga-Pedraza, MD Sub-Investigator: Olga Cantú-Rodríguez, MD Sub-Investigator: César H. Gutiérrez-Aguirre, MD Sub-Investigator: Mónica Sánchez-Cárdenas, MD Sub-Investigator: José C Jaime-Pérez, MD Sub-Investigator: Luz Tarín-Arzaga 收起 <<
NCT02158936	-		Terminated	-	-
NCT01772420	Adult Myelodysplastic Syndrome... 展开 >> Anemia Chronic Myelomonocytic Leukemia 收起 <<	Phase 2	Unknown	-	United States, Kansas ... 展开 >> University of Kansas Cancer Center Recruiting Kansas City, Kansas, United States, 66160 Contact: Suman Kambhampati 913-588-6029 skambhampati@kumc.edu Principal Investigator: Suman Kambhampati United States, New York Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10461 Contact: Amit K. Verma 718-430-8761 amit.verma@einstein.yu.edu Principal Investigator: Amit K. Verma 收起 <<
NCT01657552	Thrombocytopaenia	Phase 1	Completed	-	United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 <<
NCT01927731	Bone Marrow Transplantation Re... 展开 >>cipient Cord Blood Transplant Recipient Hematopoietic Cell Transplantation Recipient 收起 <<	Phase 2	Active, not recruiting	October 31, 2019	United States, Texas ... 展开 >> M D Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT00903929	-		Completed	-	-
NCT00424177	-		Completed	-	-
NCT01821625	Thrombocytopenia ... 展开 >> Hepatitis C 收起 <<	Phase 2 Phase 3	Unknown	-	United States, Texas ... 展开 >> UT Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390-8887 Contact: Paola Piovanetti, MS 214-645-6126 paola.piovanetti@utsouthwestern.edu Principal Investigator: William M Lee, M.D. Sub-Investigator: Perry H Dubin, BA 收起 <<
NCT00903929	Thrombocytopenia ... 展开 >> Acute Radiation Syndrome 收起 <<	Phase 1	Completed	-	-
NCT00888901	Idiopathic Thrombocytopenic Pu... 展开 >>rpura 收起 <<	Phase 4	Completed	-	-
NCT00351468	Purpura, Thrombocytopaenic, Id... 展开 >>iopathic 收起 <<	Phase 3	Completed	-	-
NCT00351468	-		Completed	-	-
NCT01439321	-		Completed	-	-
NCT03206086	Fanconi's Anemia	Phase 2	Recruiting	May 1, 2022	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov 收起 <<
NCT01484314	Thrombocytopenia ... 展开 >> Multiple Myeloma 收起 <<	Phase 2	Terminated(Low accrual.)	-	United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 收起 <<
NCT01168921	CLL Leukemia	Phase 2	Active, not recruiting	November 2019	United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT01000051	Thrombocytopenia	Phase 2	Completed	-	United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT00996216	Hepatitis C	Phase 3	Completed	-	-
NCT01484314	-		Terminated(Low accrual.)	-	-
NCT01621204	Immune Thrombocytopenic Purpur... 展开 >>a 收起 <<	Phase 3	Recruiting	January 2019	Canada, Alberta ... 展开 >> University of Alberta Hospital Recruiting Edmonton, Alberta, Canada, T6G2G3 Contact: Loree Larratt, MD 780-407-7021 llarratt@ualberta.ca Contact: Ovais Shaikh 780-407-6090 Ovais.Shaikh@albertahealthservices.ca Principal Investigator: Loree Laratt, MD Sub-Investigator: Irwindeep Sandhu, MD Canada, British Columbia Vancouver General Hospital Terminated Vancouver, British Columbia, Canada, V5Z1M9 Canada, Ontario Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada, L8N 3Z5 Contact: Donald M Arnold, MD 905-525-9140 ext 28603 arnold@mcmaster.ca Contact: Erin Jamula, MSc 905-525-9140 ext 21845 jamulae@mcmaster.ca Principal Investigator: Donald M Arnold, MD London Health Sciences Center Recruiting London, Ontario, Canada, N6A5W9 Contact: Cyrus Hsia, MD 519-685-8500 ext 56060 cyrus.hsia@lhsc.on.ca Contact: Maisam Abouzeenni Maisam.Abouzeenni@lhsc.on.ca Principal Investigator: Cyrus Hsia, MD Ottawa Hospital Recruiting Ottawa, Ontario, Canada, K1H8L6 Contact: Alan Tinmouth, MD 613-737-8899 ext 73914 Atinmouth@toh.ca Contact: Holly Carr hcarr@ohri.ca Principal Investigator: Alan Tinmouth, MD Sunnybrook Hospital Recruiting Toronto, Ontario, Canada, M4N3M5 Contact: Yulia Lin, MD 416-480-6100 ext 2781 Yulia.Lin@sunnybrook.ca Principal Investigator: Yulia Lin, MD St.Micheal's Hospital Recruiting Toronto, Ontario, Canada, M5B1W8 Contact: Michelle Sholzberg, MD 416-864-6060 SholzbergM@smh.ca Contact: Aziz Jiwajee 416-864-5354 JiwajeeA@smh.ca Principal Investigator: Michelle Sholzberg, MD Canada, Quebec Hopital Maisonneuve-Rosemont Recruiting Montreal, Quebec, Canada, H1T2M4 Contact: Jeannine Kassis, MD 514-252-3404 jkassis.hmr@ssss.gouv.qc.ca Contact: Julie Trinh Lu, B.Sc, DESS 514-252-3400 ext 3336 jtlu.hmr@ssss.gouv.qc.ca Principal Investigator: Jeannine Kassis, MD Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T1E2 Contact: Mark Blostein, MD 514-340-8214 mark.blostein@mgill.ca Contact: Vivian Pananis 514-340-8222 ext 5982 vpananis@gmail.com Principal Investigator: Mark Blostein, MD Netherlands The Haga Hospital Not yet recruiting The Hague, Netherlands Contact: Sufia Amini 31 702102556 s.amini@hagaziekenhuis.nl Contact: Okke Eissen 31 702101844 o.eissen@hagaziekenhuis.nl Principal Investigator: Martin Schipperus, MD 收起 <<
NCT00902018	Idiopathic Thrombocytopenic Pu... 展开 >>rpura 收起 <<	Phase 2	Completed	-	United States, New York ... 展开 >> Weill Cornell Medical College New York, New York, United States, 10065 收起 <<
NCT00828750	-		Completed	-	-
NCT01481220	Myelodysplastic Syndrome ... 展开 >> Thrombocytopenia 收起 <<	Phase 1	Completed	-	Sweden ... 展开 >> 4 Locations Uppsala, Stockholm, Göteborg, Umeå, Sweden 收起 <<
NCT02071901	Acute Myeloid Leukemia With Mu... 展开 >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia 收起 <<	Phase 2	Active, not recruiting	December 2018	United States, Ohio ... 展开 >> Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 收起 <<
NCT00922883	Anemia, Aplastic ... 展开 >> Anemia, Hypoplastic Thrombocytopenia 收起 <<	Phase 2	Active, not recruiting	August 31, 2018	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT00996216	-		Completed	-	-
NCT00828750	Idiopathic Thrombocytopenic Pu... 展开 >>rpura Purpura, Thrombocytopenic, Idiopathic 收起 <<	Phase 3	Completed	-	Japan ... 展开 >> GSK Investigational Site Gifu, Japan, 503-8502 GSK Investigational Site Hiroshima, Japan, 734-8551 GSK Investigational Site Ibaraki, Japan, 305-8576 GSK Investigational Site Osaka, Japan, 565-0871 GSK Investigational Site Osaka, Japan, 596-8501 GSK Investigational Site Tokyo, Japan, 160-8582 收起 <<
NCT00922883	-		Active, not recruiting	-	-
NCT01428635	Leukemia Chro... 展开 >>nic Myeloid Leukemia Myelofibrosis 收起 <<	Phase 2	Active, not recruiting	January 2020	United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT00643929	-		Completed	-	-
NCT01194167	Thrombocytopenia	Phase 2	Withdrawn(Inability to identif... 展开 >>y eligible patients) 收起 <<	-	United States, Ohio ... 展开 >> University of Cincinnati Cincinnati, Ohio, United States, 45219 收起 <<
NCT01491594	Sarcoma, Soft Tissue ... 展开 >> Osteosarcoma Neoplasms, Connective and Soft Tissue 收起 <<	Phase 1	Terminated(Unable to accrue su... 展开 >>bjects to the study.) 收起 <<	-	United States, North Carolina ... 展开 >> Duke Cancer Center Durham, North Carolina, United States, 27710 收起 <<
NCT02998645	Severe Aplastic Anemia	Phase 2	Recruiting	January 12, 2024	Brazil ... 展开 >> Novartis Investigative Site Recruiting Ribeirao Preto, SP, Brazil, 14048-900 Novartis Investigative Site Recruiting São Paulo, SP, Brazil, 01323-900 Hong Kong Novartis Investigative Site Recruiting Hong Kong, Hong Kong Hungary Novartis Investigative Site Recruiting Debrecen, Hungary, 4032 India Novartis Investigative Site Recruiting Vellore, India Italy Novartis Investigative Site Recruiting Bologna, BO, Italy, 40138 Novartis Investigative Site Recruiting Brescia, BR, Italy, 25123 Novartis Investigative Site Recruiting Milano, MI, Italy, 20122 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 06351 Netherlands Novartis Investigative Site Recruiting Leiden, Netherlands, 2300 RC Spain Novartis Investigative Site Recruiting San Sebastian, Pais Vasco, Spain, 20080 Novartis Investigative Site Recruiting Madrid, Spain, 28041 Novartis Investigative Site Recruiting Madrid, Spain, 28222 Thailand Novartis Investigative Site Recruiting Bangkok, Thailand, 10700 Novartis Investigative Site Recruiting Chiang Mai, Thailand, 50200 Turkey Novartis Investigative Site Recruiting Istanbul, Turkey, 34890 Novartis Investigative Site Recruiting Samsun, Turkey, 55139 收起 <<
NCT01703169	Severe Aplastic Anemia ... 展开 >> Very Severe Aplastic Anemia Moderate Aplastic Anemia 收起 <<	Phase 2	Completed	-	United States, Utah ... 展开 >> University of Utah Salt Lake City, Utah, United States, 84112 收起 <<
NCT01762761	Purpura, Thrombocytopenic, Idi... 展开 >>opathic and Hepatitis C 收起 <<	Phase 3	Active, not recruiting	November 15, 2018	China, Fujian ... 展开 >> Novartis Investigative Site Fuzhou, Fujian, China, 350001 China, Guangdong Novartis Investigative Site Guangzhou, Guangdong, China, 510080 Novartis Investigative Site Guangzhou, Guangdong, China, 510515 Novartis Investigative Site Zhongshan, Guangdong, China, 528403 China, Hunan Novartis Investigative Site Changsha, Hunan, China, 410013 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210029 China, Jiangxi Novartis Investigative Site Nanchang, Jiangxi, China, 330006 China, Shandong Novartis Investigative Site Jianan, Shandong, China, 250012 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Beijing, China, 100034 Novartis Investigative Site Beijing, China, 100044 Novartis Investigative Site Beijing, China, 100083 Novartis Investigative Site Beijing, China, 100730 Novartis Investigative Site Chengdu, China, 610041 Novartis Investigative Site Jiang Su Province, China, 215006 Novartis Investigative Site Shanghai, China, 200025 Novartis Investigative Site Shanghai, China Novartis Investigative Site Tianjin, China, 300020 收起 <<
NCT02281370	Purpura, Thrombocytopenic, Idi... 展开 >>opathic 收起 <<	Phase 1	Completed	-	United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 <<
NCT01055600	Thrombocytopaenia	Phase 4	Withdrawn(Protocol opened to r... 展开 >>ecruitment in Nov 2009. No potential subjects identified in 5 years; therefore, study was terminated in Jul 2014 due to lack of feasibility) 收起 <<	July 2014	United States, North Carolina ... 展开 >> GSK Investigational Site Research Triangle Park, North Carolina, United States, 27709 收起 <<
NCT01893372	Leukemia	Phase 2	Active, not recruiting	October 2019	United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT01891994	-		Active, not recruiting	-	-
NCT01550185	Adult Acute Basophilic Leukemi... 展开 >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia 收起 <<	Phase 1	Terminated(Sponsor wanted stud... 展开 >>y rewritten) 收起 <<	-	United States, Georgia ... 展开 >> Emory University, Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 收起 <<
NCT01286675	Multiple Myeloma	Early Phase 1	Active, not recruiting	December 2018	United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 收起 <<
NCT01762761	-		Active, not recruiting	-	-
NCT02404025	Cytopaenia	Phase 2	Completed	-	Japan ... 展开 >> Novartis Investigative Site Aichi, Japan, 453-8511 Novartis Investigative Site Aichi, Japan, 460-0001 Novartis Investigative Site Ibaraki, Japan, 305-8576 Novartis Investigative Site Ishikawa, Japan, 920-8641 Novartis Investigative Site Miyagi, Japan, 981-1293 Novartis Investigative Site Okayama, Japan, 700-0962 Novartis Investigative Site Osaka, Japan, 530-0012 Novartis Investigative Site Osaka, Japan, 543-8555 Novartis Investigative Site Osaka, Japan, 565-0871 Novartis Investigative Site Tochigi, Japan, 329-0498 Novartis Investigative Site Tokyo, Japan, 141-8625 收起 <<
NCT03771378	Primary Immune Thrombocytopeni... 展开 >>a 收起 <<	Phase 4	Not yet recruiting	September 15, 2019	-
NCT01703169	-		Completed	-	-
NCT03603795	Acute Myeloid Leukemia	Phase 2	Recruiting	September 2024	France ... 展开 >> CHU ANGERS - Maladies du sang Not yet recruiting Angers, France, 49933 Contact: Mathilde HUNAULT, Dr 02 41 35 45 82 mahunault@chu-angers.fr CH de la Côte Basque - Hématologie Not yet recruiting Bayonne, France, 64109 Contact: Anne BANOS, Dr +33 5 59 44 38 32 abanos@ch-cotebasque.fr CHU Estaing Not yet recruiting Clermont-Ferrand, France, 63003 Contact: Aurélie RAVINET, Dr 04 73 75 00 65 aravinet@chu-clermontferrand.fr CHU Grenoble - Hématologie Clinique Recruiting Grenoble, France, 38043 Contact: Claude-Eric BULABOIS, Dr 04 76 76 57 55 cebulabois@chu-grenoble.fr Institut Paoli-Calmettes - Hématologie 2 Not yet recruiting Marseille, France, 13000 Contact: Norbert VEY, Pr +33 4 91 22 36 95 veyn@ipc.unicancer.fr Hôpital Saint-Eloi - Hématologie Clinique Not yet recruiting Montpellier, France, 34295 Contact: Yosr HICHERI, Dr +33 4 67 33 24 18 y-hicheri@chu-montpellier.fr HOPITAL E. MULLER - Hématologie Not yet recruiting Mulhouse, France, 68070 Contact: Mario OJEDA-URIBE, Dr +33(0)3 89 64 77 55 ojeda-uribem@ghrmsa.fr CHU HOTEL DIEU - Hématologie Clinique Not yet recruiting Nantes, France, 44093 Contact: Pierre PETERLIN, Dr +33(0)2 40 08 32 71 pierre.peterlin@chu-nantes.fr CHU Caremeau Not yet recruiting Nîmes, France, 30029 Contact: Eric JOURDAN, Dr 04 66 68 32 31 eric.jourdan@chu-nimes.fr CHU La Milétrie - Hématologie Clinique Not yet recruiting Poitiers, France, 86000 Contact: Maria-Pilar GALLEGO-HERNANZ, Dr +33(0)5 49 44 44 44 maria-pilar.gallego-hernanz@chu-poitiers.fr CHU Pontchaillou Not yet recruiting Rennes, France, 35033 Contact: Marc BERNARD, Dr 02 40 08 32 71 marc.bernard@chu-rennes.fr CHU Hautepierre - Hématologie Not yet recruiting Strasbourg, France, 67098 Contact: Bruno LIOURE, Dr +33(0)3 88 12 76 76 bruno.lioure@chru-strasbourg.fr Institut Universitaire du Cancer de Toulouse Oncopole - Service d'Hématologie Recruiting Toulouse, France, 31059 Contact: Christian RECHER, Pr +33 5 31 15 63 55 recher.christian@iuct-oncopole.fr Sponsor FILO Not yet recruiting Tours, France, 37044 Contact: Mélanie COTTOT, Mrs +33247478899 m.dupin@chu-tours.fr CHU de Brabois Not yet recruiting Vandœuvre-lès-Nancy, France, 54500 Contact: Caroline BONMATI, Dr 03 83 15 52 49 c.bonmati@chu-nancy.fr 收起 <<
NCT03754634	Thrombocytopenia	Phase 2	Not yet recruiting	September 1, 2020	China, Shandong ... 展开 >> Qilu hospital, Shandong University Recruiting Jinan, Shandong, China Contact: Ming Hou, doctor houming@medmail.com.cn 收起 <<
NCT01891994	Severe Aplastic Anemia (SAA)	Phase 2	Active, not recruiting	December 31, 2021	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT01386723	-		Terminated	-	United States, New York ... 展开 >> Weill Cornell Medical College/New York Presbyterian Hospital New York, New York, United States, 10065 收起 <<
NCT01656252	-		Terminated(Study stopped per N... 展开 >>ovartis request due to futility from another study.) 收起 <<	-	-
NCT01656252	Acute Myeloid Leukemia	Phase 1 Phase 2	Terminated(Study stopped per N... 展开 >>ovartis request due to futility from another study.) 收起 <<	-	United States, Massachusetts ... 展开 >> University of Massachusetts Worcester Worcester, Massachusetts, United States, 01655 United States, Minnesota Mayo Clinic, Rochester Rochester, Minnesota, United States, 55905 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 United States, Pennsylvania Penn State Hershey Cancer Institute Hershey, Pennsylvania, United States, 17033 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 收起 <<
NCT01286038	Myelodysplastic Syndrome (MDS)... 展开 >> Thrombocytopenia 收起 <<	Phase 1 Phase 2	Active, not recruiting	April 2020	United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 <<
NCT01652599	Immune Thrombocytopenic Purpur... 展开 >>a 收起 <<	Phase 2	Completed	-	Mexico ... 展开 >> Hospital Universitario "Dr. Jose E. Gonzalez" UANL Monterrey, Nuevo Leon, Mexico, 64460 收起 <<
NCT02422394	Inherited Platelet Disorder	Phase 2	Completed	-	Italy ... 展开 >> Department of Internal Medicine, Hospital of Padova Padova, Italy, 35128 Unit of Internal Medicine 3, IRCCS Policlinico San Matteo Foundation Pavia, Italy, 27100 Section of Internal and Cardiovascular Medicine, Department of Medicine, University Hospital of Perugia Perugia, Italy, 06126 收起 <<
NCT02010645	Leukemia	Phase 2	Active, not recruiting	March 2019	United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT02773225	Anemia, Aplastic	Phase 2 Phase 3	Recruiting	September 30, 2023	Germany ... 展开 >> University Hospital Ulm Recruiting Ulm, Germany, 89081 Contact: Britta Höchsmann, MD hoechsmann@blutspende.de 收起 <<
NCT01397149	Chronic Lymphocytic Leukemia ... 展开 >> Thrombocytopenia 收起 <<	Phase 1 Phase 2	Terminated(Insufficient recrui... 展开 >>tment) 收起 <<	-	Austria ... 展开 >> Medizinische Universität Wien, Innere Medizin I, Abt. Hämatologie und Hämastaseologie Vienna, Austria, 1090 Germany Universitätsklinikum Köln; Klinik I für Innere Medizin Cologne, Germany, 50924 Universitätsklinikum Carl Gustav Carus Med. Klinik und Poliklinik I Dresden, Germany, 01307 Gemeinschaftspraxis für Innere Medizin, Hämatologie und Internistische Onkologie Erlangen, Germany, 91052 Universitätsklinikum; Klinik für Hämatologie Essen, Germany, 45147 Klinikum Frankfurt (Oder) Medizinische Klinik I Frankfurt (Oder), Germany, 15236 Universitätsklinikum Schleswig-Holstein, II. Medizinische Klinik und Poliklinik im Städtischen Krankenhaus Kiel, Germany, 24116 Onkologische Schwerpunktpraxis Leer-Emden Leer, Germany, 26789 Städtisches Klinikum München GmbH, Klinikum Schwabing, Klinik für Hämatologie, Immunologie, Palliativmedizin, Infektiologie und Tropenmedizin München, Germany, 80804 Universitätsklinikum Ulm, Medizinische Klinik III Ulm, Germany, 89081 收起 <<
NCT01133860	-		Completed	-	-
NCT02201290	Purpura, Thrombocytopenic, Idi... 展开 >>opathic 收起 <<	Phase 3	Completed	-	Russian Federation ... 展开 >> Novartis Investigative Site Krasnodar, Russian Federation, 350007 Novartis Investigative Site Moscow, Russian Federation, 117997 Novartis Investigative Site Saint Petersburg, Russian Federation, 198205 收起 <<
NCT03524612	Immune Thrombocytopenic Purpur... 展开 >>a (ITP) 收起 <<	Phase 2	Recruiting	November 16, 2020	United States, New York ... 展开 >> Hematology Oncology Association of Rockland Drug Shipment Recruiting Nyack, New York, United States, 10960 Contact 845-348-2657 Principal Investigator: Bradley Cohen Austria Novartis Investigative Site Recruiting A-1090 Vienna, Austria Novartis Investigative Site Recruiting Wien, Austria, 1140 Spain Novartis Investigative Site Recruiting Salamanca, Castilla Y Leon, Spain, 37007 Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Recruiting Majadahonda, Madrid, Spain, 28222 Novartis Investigative Site Recruiting Malaga, Spain, 29010 Novartis Investigative Site Recruiting Murcia, Spain, 30008 收起 <<
NCT02323178	CMML Thromboc... 展开 >>ytopenia 收起 <<	Phase 1 Phase 2	Active, not recruiting	December 2019	France ... 展开 >> CHU d'Amiens Amiens, France, 80054 CHU d'Angers Angers, France, 49 033 CH Victor Dupouy Argenteuil, France, 95107 Hôpital Avicenne Bobigny, France, 93009 Hôpital privé Sévigné Cesson-Sévigné, France, 35510 CHU Henri Mondor Créteil, France, 94010 CHU de Grenoble Grenoble, France, 38043 CH Le Mans Le Mans, France, 72037 CHRU de Limoges Limoges, France, 87046 Centre Hospitalier Lyon Sud Lyon, France, 69495 Institut Paoli Calmettes Marseille, France, 13009 Centre Hospitalier de Meaux Meaux, France, 77100 CHU de Nantes Nantes, France, 44093 Centre Catherine de Sienne Nantes, France, 44277 Hôpital Archet 1 Nice, France, 06202 Hôpital Saint Louis - Service d'hématologie AJA Paris, France, 75010 Hôpital Saint Louis - Service d'hématologie séniors Paris, France, 75010 CHU de Haut-Lévèque Pessac, France, 33604 CHU de Poitiers Poitiers, France, 86021 Centre Hospitalier de la région d'Annecy Pringy cedex, France, 74374 Hôpital Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France, 76038 Hôpital Purpan - Médecine interne Toulouse, France, 31059 Hôpital Purpan - Service d'Hématologie Clinique Toulouse, France, 31059 CHU Brabois Vandoeuvre Les Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, 94805 收起 <<
NCT03412188	Idiopathic Thrombocytopenic Pu... 展开 >>rpura 收起 <<	Not Applicable	Recruiting	November 2019	Egypt ... 展开 >> Ainshams University , Faculty of medicine , Pediatric Hematology&Oncology unit, children hospital. Recruiting Cairo, Egypt, 11579 Contact: Micheal morcos, M.Sc mekoo_828@yahoo.com Contact: Mahmoud Kenny, MD moudykenny@yahoo.com Principal Investigator: Azza AG Tantawy, MD Sub-Investigator: Nayera HK El Sherif, MD Sub-Investigator: Fatma S Ebeid, MD Sub-Investigator: Eman AR Ismail, MD Sub-Investigator: Mahmoud A Kenny, MD Sub-Investigator: Michael BE morcos, M.Sc 收起 <<
NCT01757145	Hematological Malignancy ... 展开 >> Bone Marrow Failure Syndrome 收起 <<	Phase 2	Unknown	June 2016	Israel ... 展开 >> Hadassah hospital Recruiting Jerusalem, Israel Contact: Michael Shapira, MD 972-50-7874433 Davidof Cancer Center, Beilinson hospital, Rabin medical center Recruiting Petach Tikva, Israel Contact: Moshe Yeshurun, MD 972-50-4065543 moshey@clalit.org.il Principal Investigator: Moshe Yeshurun, MD 收起 <<
NCT01133860	Blood Platelet Disorders	Phase 2	Completed	-	Italy ... 展开 >> Azienda Ospedaliero-Universitaria di Padova, Unità di Medicina Generale e Patologia Speciale Padova, Italy, 35128 Fondazione IRCCS Policlinico San Matteo, Unità di Medicina III Pavia, Italy, 27100 Policlinico Monteluce, Sezione di Medicina Interna e Cardiovascolare Perugia, Italy, 06122 收起 <<
NCT03515096	Eltrombopag H... 展开 >>ematopoietic Stem Cell Transplantation Thrombocytopenia 收起 <<	Phase 3	Not yet recruiting	June 1, 2021	-
NCT01940562	Pediatric Patients Undergoing ... 展开 >>Allogeneic Cord Blood Transplantation. 收起 <<	Phase 2	Unknown	June 2016	Israel ... 展开 >> Hadassah hospital Recruiting Jerusalem, Israel Contact: Michael Shapira, MD 972-50-7874433 Schneider Children's Medical Center of Israel Recruiting Petah Tikva, Israel, 49202 Contact: Jerry Stein, MD 972-50-4057148 jstein@clalit.org.il Principal Investigator: Jerry Stein, MD 收起 <<
NCT01791101	Thrombocytopenia	Phase 2	Recruiting	December 2018	Italy ... 展开 >> UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Recruiting Bari, Italy Contact: Giorgina Specchia, Pr. Principal Investigator: Giorgina Specchia, Pr. Sub-Investigator: Domenico Pastore, Dr. Divisione di Ematologia - Ospedali Riuniti Recruiting Bergamo, Italy Contact: Alessandro Rambaldi Principal Investigator: Alessandro Rambaldi USD Trapianti di midollo per adulti - Cattedra di Ematologia - Università degli Studi di Brescia Recruiting Brescia, Italy Contact: Domenico Russo Principal Investigator: Domenico Russo Ospedale Santa Croce Divisione di Ematologia Cuneo Recruiting Catania, Italy Contact: Giuseppe Milone, Dr. Principal Investigator: Giuseppe Milone, Dr. Sub-Investigator: Salvatore Leotta, Dr. Ospedale Santa Croce Divisione di Ematologia Cuneo Recruiting Cuneo, Italy Contact: Nicola Mordini, Dr. Principal Investigator: Nicola Mordini, Dr. Sub-Investigator: Davide Rapezzi, Dr. Policlinico di Careggi Recruiting Firenze, Italy Contact: Alberto Bosi, Dr. Principal Investigator: Alberto Bosi, Dr. Sub-Investigator: Stefano Guidi, Dr. Divisione Ematologia 2 - Azienda Ospedaliera Universitaria - S.Martino Recruiting Genova, Italy Contact: Andrea Bacigalupo, Dr. Principal Investigator: Andrea Bacigalupo, Dr. Unità Trapianto di Midollo Ist. Nazionale Tumori Recruiting Milano, Italy Contact: Paolo Corradini Principal Investigator: Paolo Corradini Sub-Investigator: Francesco Spina La Maddalena Casa di Cura di Alta Specialità Dipartimento Oncologico di III Livello Not yet recruiting Palermo, Italy Contact: Maurizio Musso, Pr. Principal Investigator: Maurizio Musso, Pr. Sub-Investigator: Alessandra Crescimano, Dr. U.O. Ematologia Clinica - Azienda USL di Pescara Recruiting Pescara, Italy Contact: Pasqua Bavaro, Dr. Principal Investigator: Pasqua Bavaro, Dr. Sub-Investigator: Elsa Pennese, Dr. Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Not yet recruiting Roma, Italy Contact: Simona Sica Principal Investigator: Simona Sica Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Recruiting Roma, Italy Contact: Roberto Foà Principal Investigator: Roberto Foà Sub-Investigator: Anna Paola Iori Università degli Studi - Policlinico di Tor Vergata Not yet recruiting Roma, Italy Contact: Giorgio Arcese Principal Investigator: Giorgio Arcese Sub-Investigator: Alessandra Picardi Clinica Ematologica - Policlinico Universitario Recruiting Udine, Italy Contact: Francesco Zaja, Dr. Principal Investigator: Francesco Zaja, Dr. Sub-Investigator: Marianna Chizzotto, Dr. ULSS N. 6 Ospedale S. Bortolo Recruiting Vicenza, Italy Contact: Carlo Borghero Principal Investigator: Carlo Borghero ULSS N.6 Osp. S. Bortolo Recruiting Vicenza, Italy Contact: Carlo Borghero, Dr. Principal Investigator: Carlo Borghero, Dr. 收起 <<
NCT01488565	Myelodysplastic Syndromes (MDS... 展开 >>) Acute Myeloid Leukaemia (AML) 收起 <<	Phase 2	Completed	-	Australia, Victoria ... 展开 >> Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia, 3002 Cabrini Hospital Malvern, Victoria, Australia, 3144 收起 <<
NCT03413306	Acquired Aplastic Anemia	Phase 3	Recruiting	December 20, 2019	Russian Federation ... 展开 >> Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology Recruiting Moscow, Russian Federation, 117198 Contact: Zhanna Shekhovtsova 4956647078 zhanna.shekhovtsova@fccho-moscow.ru Contact: Eugene Pashanov, Prof. PhD +79262205578 e.pashanov@gmail.com Sub-Investigator: Olga Goronkova 收起 <<
NCT02148133	Cytopaenia	Phase 2	Completed	-	Japan ... 展开 >> Novartis Investigative Site Aichi, Japan, 453-8511 Novartis Investigative Site Aichi, Japan, 460-0001 Novartis Investigative Site Hyogo, Japan, 664-8540 Novartis Investigative Site Ibaraki, Japan, 305-8576 Novartis Investigative Site Ishikawa, Japan, 920-8641 Novartis Investigative Site Miyagi, Japan, 981-1293 Novartis Investigative Site Okayama, Japan, 700-0962 Novartis Investigative Site Osaka, Japan, 530-0012 Novartis Investigative Site Osaka, Japan, 543-8555 Novartis Investigative Site Osaka, Japan, 565-0871 Novartis Investigative Site Tochigi, Japan, 329-0498 Novartis Investigative Site Tokyo, Japan, 141-8625 收起 <<
NCT03664518	Thrombocytopenia Purpura ... 展开 >> Chronic HBV Infection 收起 <<	Phase 2	Not yet recruiting	May 31, 2020	China, Tianjin ... 展开 >> Ethics Committee of Blood disease hospital, Chinese Academy of Medical Sciences Active, not recruiting Tianjin, Tianjin, China, 300020 收起 <<
NCT02254434	Cirrhosis, Liver	Phase 1	Completed	-	Mexico ... 展开 >> GSK Investigational Site Mexico City, Mexico, 14610 收起 <<
NCT01880047	Immune Thrombocytopenia ... 展开 >> Platelet Disorder 收起 <<	Phase 2	Active, not recruiting	March 30, 2019	United States, New York ... 展开 >> Weill Cornell Medicine New York, New York, United States, 10065 收起 <<
NCT01500538	Follicular Lymphoma ... 展开 >> Marginal Zone Lymphoma Mantle Cell Lymphoma 收起 <<	Phase 2	Terminated(Poor recruitment ra... 展开 >>te) 收起 <<	-	Australia, Victoria ... 展开 >> Peter MacCallum Cancer Centre Melbourne, Victoria, Australia, 3002 收起 <<
NCT03638817	Thrombocytopenia	Phase 2	Not yet recruiting	September 2021	-
NCT01610180	Purpura, Thrombocytopenic, Idi... 展开 >>opathic Autoimmune Thrombocytopenic Purpura Autoimmune Thrombocytopenia Chronic Lymphocytic Leukemia Non Hodgkin's Lymphoma 收起 <<	Phase 2	Completed	-	Italy ... 展开 >> Department of Hematology, Ospedale San Bortolo Vicenza, Italy, 36100 收起 <<
NCT03243656	Eltrombopag	Phase 4	Not yet recruiting	December 2020	-
NCT03701217	Eltrombopag T... 展开 >>hrombocytopenia Acute Myeloid Leukemia 收起 <<	Phase 2 Phase 3	Recruiting	October 2019	China, Guangdong ... 展开 >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Dan Xu +86-20-61641615 xudan2@medmail.com.cn 收起 <<
NCT03437603	Poor Graft Function	Phase 2	Not yet recruiting	January 2020	China, Jiangsu ... 展开 >> the First Affiliated Hospital of Soochow University Not yet recruiting Suzhou, Jiangsu, China Contact: Xiaowen Tang, MD 8613913538266 tangxiaowen@suda.edu.cn 收起 <<
NCT02402998	Primacy Immune Thrombocytopeni... 展开 >>a 收起 <<	Phase 2	Active, not recruiting	October 2018	Italy ... 展开 >> Azienda Ospedaliera Di Bologna Policlinico S. Orsola - Malpighi Bologna, Italy, 40138 Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia- Padiglione Marcora 2° piano Milano, Italy Ospedale Niguarda " Ca Granda" - SC Ematologia Blocco SUD, Ponti Est, Scala E, 4° piano Milano, Italy Azienda Ospedaliera "S.Gerardo" Monza, Italy Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli" Napoli, Italy S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro Novara, Italy Azienda Ospedale S. Luigi at University of Torino Orbassano, Italy, 10043 AO di Padova Università degli Studi Padova Dipartimento di Medicina Clinica Medica I - Medicina Interna CLOPD Padova, Italy Ospedale "Infermi" Rimini, Italy Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore Rome, Italy, 00168 Clinica Ematologica-Centro Trapianti e Terapie cellulari Azienda Ospedaliero-Universitaria, Udine Udine, Italy Università degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi Verona, Italy Ospedale San Bortolo Vicenza, Italy, 36100 收起 <<
NCT02093325	Solid Tumor	Phase 3	Enrolling by invitation	August 2019	Taiwan ... 展开 >> Department of Obstetrics & Gynecology and Department of Oncology Chang Gung Memorial Hospital Chiayi City, Taiwan Department of Obstetrics & Gynecology Chang Gung Memorial Hospital Kaohsiung, Taiwan Division of Gynecologic Oncology, Department of Obstetrics & Gynecology and Division of Oncology Chang Gung Memorial Hospital Linkou, Taiwan 收起 <<
NCT03718533	Poor Graft Function	Phase 2	Not yet recruiting	March 1, 2021	Spain ... 展开 >> Hospital de la Santa Creu i Sant Pau Not yet recruiting Barcelona, Spain Hospital Ramón y Cajal Not yet recruiting Madrid, Spain Hospital Carlos Haya Not yet recruiting Málaga, Spain Hospital Son Espases Not yet recruiting Palma de Mallorca, Spain Hospital Universitario de Salamanca Not yet recruiting Salamanca, Spain Hospital Universitario de Donosti Not yet recruiting San Sebastián, Spain, 20014 Hospital Clínico de Valencia Not yet recruiting Valencia, Spain Hospital Alvaro Cunqueiro Not yet recruiting Vigo, Spain 收起 <<

CAS号	496775-61-2
分子式	C₂₅H₂₂N₄O₄
分子量	442.47
SMILES Code	O=C(C1=CC(C2=CC=CC(N/N=C3C(C)=NN(C4=CC=C(C)C(C)=C4)C/3=O)=C2O)=CC=C1)O
MDL No.	MFCD20926253

别名	SB-497115
运输	蓝冰
InChI Key	SVOQIEJWJCQGDQ-UHFFFAOYSA-N
Pubchem ID	135449332

Eltrombopag/艾曲波帕 {[allProObj[0].p_purity_real_show]}

Eltrombopag/艾曲波帕纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Eltrombopag/艾曲波帕质控信息

Eltrombopag/艾曲波帕生物活性

Eltrombopag/艾曲波帕临床研究

Eltrombopag/艾曲波帕参考文献

Eltrombopag/艾曲波帕实验方案

Eltrombopag/艾曲波帕技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Eltrombopag/艾曲波帕 {[allProObj[0].p_purity_real_show]}

Eltrombopag/艾曲波帕 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Eltrombopag/艾曲波帕 质控信息

Eltrombopag/艾曲波帕 生物活性

Eltrombopag/艾曲波帕 临床研究

Eltrombopag/艾曲波帕 参考文献

Eltrombopag/艾曲波帕 实验方案

Eltrombopag/艾曲波帕 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Eltrombopag/艾曲波帕纯度/质量文件产品仅供科研

Eltrombopag/艾曲波帕质控信息

Eltrombopag/艾曲波帕生物活性

Eltrombopag/艾曲波帕临床研究

Eltrombopag/艾曲波帕参考文献

Eltrombopag/艾曲波帕实验方案

Eltrombopag/艾曲波帕技术信息